Biotech firm Gene Logic has obtained shareholder approval to change its name to Ore Pharmaceutics Inc. and sell its genomics division to Ocimum Biosolutions, which will inherit the Gene Logic name. The Gaithersburg, Md.-based company plans to complete the changes later in the week as part of its agenda to focus on drug repositioning.

Related Summaries